# Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer

> **NCT07718672** · PHASE2 · RECRUITING · sponsor: **Roswell Park Cancer Institute** · enrollment: 200 (estimated)

## Conditions studied

- Early Stage Lung Non-Small Cell Carcinoma
- Stage I Lung Cancer AJCC v8
- Stage II Lung Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Lymph Node Biopsy
- **PROCEDURE:** Positron Emission Tomography
- **RADIATION:** Stereotactic Body Radiation Therapy
- **RADIATION:** Stereotactic Body Radiation Therapy
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT07718672
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-06-25
- **Final completion:** 2029-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718672, "Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07718672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*